Business Description
Infant Bacterial Therapeutics AB
ISIN : SE0008015259
Share Class Description:
OSTO:IBT B: Class BCompare
Compare
Traded in other countries / regions
IBT B.SwedenIFTBF.USA9IB.GermanyIBTBs.UK IPO Date
2016-03-29Description
Infant Bacterial Therapeutics AB is a pharmaceutical company. Its purpose is to develop and commercialize drugs for diseases affecting premature babies. Its focus is on the drug candidate IBP-9414, whose development program is designed to show a reduced incidence of necrotizing enterocolitis (NEC) and improved gastrointestinal function (SFT) when treated with IBP-9414's active substance Lactobacillus reuteri bacterial strain naturally found in human breast milk. Its portfolio also includes additional drug candidates, IBP-1016, IBP-1118 and IBP-1122. IBP1016, for the treatment of gastroschisis, is a life-threatening and rare disorder in which children are born with externalized gastrointestinal organs.
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.8 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -16.1 | |||||
3-Year EPS without NRI Growth Rate | -15.8 | |||||
3-Year FCF Growth Rate | -16.3 | |||||
3-Year Book Growth Rate | -16.7 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 52.4 | |||||
9-Day RSI | 51.2 | |||||
14-Day RSI | 52.26 | |||||
6-1 Month Momentum % | 3.27 | |||||
12-1 Month Momentum % | 73.54 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.74 | |||||
Quick Ratio | 4.74 | |||||
Cash Ratio | 4.33 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.3 | |||||
Shareholder Yield % | -7.64 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -42.28 | |||||
ROA % | -36.94 | |||||
ROIC % | -477.43 | |||||
ROCE % | -42.28 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 4.79 | |||||
Price-to-Tangible-Book | 4.96 | |||||
EV-to-EBIT | -7.93 | |||||
EV-to-EBITDA | -7.98 | |||||
EV-to-FCF | -10.45 | |||||
Price-to-Net-Current-Asset-Value | 4.96 | |||||
Price-to-Net-Cash | 5.58 | |||||
Earnings Yield (Greenblatt) % | -12.61 | |||||
FCF Yield % | -7.34 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Infant Bacterial Therapeutics AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | |||
EPS (TTM) (kr) | -10.03 | ||
Beta | 0 | ||
Volatility % | 73.42 | ||
14-Day RSI | 52.26 | ||
14-Day ATR (kr) | 4.154711 | ||
20-Day SMA (kr) | 98.915 | ||
12-1 Month Momentum % | 73.54 | ||
52-Week Range (kr) | 56 - 106.5 | ||
Shares Outstanding (Mil) | 13.47 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Infant Bacterial Therapeutics AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Infant Bacterial Therapeutics AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Infant Bacterial Therapeutics AB Frequently Asked Questions
What is Infant Bacterial Therapeutics AB(OSTO:IBT B)'s stock price today?
The current price of OSTO:IBT B is kr98.60. The 52 week high of OSTO:IBT B is kr106.50 and 52 week low is kr56.00.
When is next earnings date of Infant Bacterial Therapeutics AB(OSTO:IBT B)?
The next earnings date of Infant Bacterial Therapeutics AB(OSTO:IBT B) is 2024-08-28.
Does Infant Bacterial Therapeutics AB(OSTO:IBT B) pay dividends? If so, how much?
Infant Bacterial Therapeutics AB(OSTO:IBT B) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |